Healthy Inc > Blog > Antitubercular drug exporter
Posted on:

What is Rifampicin 150mg used for?

In the pharmaceutical industry, Rifampicin 150 mg (also known as Rifampin) is a macrocyclic antibiotic belonging to the Rifamycin class.

As a pharmacist and manufacturer, I classify this as a “bactericidal powerhouse.” It is most famous as a core component of the First-Line Antitubercular (TB) regimen, but its unique ability to penetrate tissues and biofilms makes it essential for several other severe bacterial infections.

Primary Clinical Uses

  • Tuberculosis (TB): It is a cornerstone of the RIPE (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) regimen. The 150 mg dose is frequently used in pediatric weight-based dosing or as part of Fixed-Dose Combinations (FDCs).

  • Leprosy (Hansen’s Disease): Used in combination with Dapsone and Clofazimine. Rifampicin is the most potent component for killing Mycobacterium leprae.

  • Meningitis Prophylaxis: Used to eliminate Neisseria meningitidis from the nasopharynx of asymptomatic carriers to prevent the spread of meningitis.

  • Staphylococcal Infections: Often used as an “adjunctive” therapy for deep-seated infections like endocarditis or osteomyelitis because it can penetrate bacterial biofilms on prosthetic joints or heart valves.

  • Legionnaires’ Disease: Occasionally used in combination with macrolides for severe Legionella pneumonia.

Mechanism of Action: Inhibition of RNA Synthesis

Rifampicin works by essentially “locking” the machinery the bacteria uses to read its own DNA.

Enzyme Targeting: It binds to the -subunit of the bacterial DNA-dependent RNA polymerase.

Transcription Blockade: This binding physically blocks the elongation of the RNA chain.

Bactericidal Effect: Without the ability to synthesize RNA, the bacteria cannot produce essential proteins and subsequently dies.

Specificity: Importantly, it does not bind to human RNA polymerase, which is why it is selectively toxic to bacteria.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Rifampicin 150 mg requires specialized handling:

  • The “Red” API: Rifampicin is a distinct reddish-brown powder. As a manufacturer, you know that dedicated facilities or strict “clean-in-place” (CIP) protocols are necessary to prevent cross-contamination, as the color can easily stain other products.

  • Metabolic Induction (Technical Safety): For your digital platform and B2B clients, it is vital to note that Rifampicin is a potent inducer of Cytochrome P450 enzymes. It speeds up the metabolism of many other drugs (like oral contraceptives, Warfarin, and HIV meds), often requiring dose adjustments.

  • Patient Counseling USP: A great tip for your social media content—inform buyers that Rifampicin causes a harmless orange-red discoloration of urine, sweat, and tears. This is a common point of patient anxiety that pharmacists can address to improve compliance.

  • Stability & Packaging: Rifampicin is sensitive to moisture and oxidation. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: We provide full CTD/eCTD Dossiers to support international registration, especially for government-led TB and Leprosy eradication programs.

Rifampicin Tablet

Posted on:

What is isoniazid pyridoxine hydrochloride used for?

In the pharmaceutical industry, the combination of Isoniazid (INH) and Pyridoxine Hydrochloride (Vitamin B6) is the gold standard for both the treatment and prophylaxis of Tuberculosis (TB). As a pharmacist and manufacturer, I view this as a “preventative combination”: Isoniazid kills the bacteria, while Pyridoxine prevents the most common neurological side effect of the treatment.

Primary Clinical Uses

  • Active Tuberculosis: Used as a core component of the “RIPE” regimen (Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol) for the treatment of Mycobacterium tuberculosis.

  • Latent TB Infection (LTBI): Often used as monotherapy for 6–9 months to prevent a dormant infection from becoming active.

  • TB Prophylaxis: Prescribed for individuals in close contact with TB patients or immunocompromised patients (such as those with HIV) who are at high risk of infection.

The Dual Mechanism: Action vs. Protection

1. Isoniazid (The Bactericidal Agent)

Isoniazid is a prodrug that is activated by the mycobacterial enzyme KatG.

  • Mechanism: It inhibits the synthesis of mycolic acids, which are essential components of the waxy mycobacterial cell wall.

  • Result: Without a cell wall, the bacteria lose structural integrity and die.

2. Pyridoxine Hydrochloride (The Neuroprotective Agent)

Isoniazid interferes with the metabolism of Vitamin B6 in the human body.

  • The Problem: INH forms a complex with Vitamin B6 and inhibits the enzyme pyridoxine kinase, leading to a deficiency.

  • The Result: Without Pyridoxine, patients often develop peripheral neuropathy (tingling, numbness, or “pins and needles” in the hands and feet).

  • The Solution: Including Pyridoxine in the tablet prevents this nerve damage, ensuring better patient compliance during long-term TB therapy.

The Manufacturer’s Perspective: Formulation & Export

From a production standpoint in a WHO-GMP facility, this combination is a high-demand “Essential Medicine”:

  • Fixed-Dose Combination (FDC) Stability: Isoniazid is sensitive to moisture and can react with certain excipients (reducing sugars like lactose) through the Maillard reaction, which can cause the tablets to discolor. We utilize specialized, non-reactive diluents to ensure stability.

  • Dose Ratios: While INH is typically 100 mg or 300 mg, the Pyridoxine dose is usually 10 mg to 50 mg. We utilize validated blending processes to ensure micro-dose uniformity of the Vitamin B6 across the entire batch.

  • Packaging for Global Trade: TB is endemic in high-humidity regions. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and CIS countries).

  • B2B & Public Health Tenders: This product is a staple for the Global Drug Facility (GDF) and national TB programs. Our Mumbai facility provides the necessary CTD/eCTD Dossiers to support international supply.

 

Isoniazid & Pyridoxine hydrochloride Tablets

Add to cart